• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ERIS Lifesciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 66197.0
  • ISIN : INE406M01024
1,271.20 -24 (-1.86%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    1,263.60

  • Today’s High

    1,300.00

  • Open

    1,295.50

  • Perv Close

    1,295.30

  • 52W Low

    1,200.00

  • 52W High

    1,740.00

Key Indicators

  • P/E(TTM)

    85.62

  • Mar.Cap (₹Cr.)

    17,616.71

  • Div & Yield %

    0.57

  • Book Value(₹)

    230.58

  • Debt-Equity Ratio

    -1.86

  • AGM Date

    22-Sep-2026

  • EPS

    14.88

  • P/E Ratio

    85.62

Financials Ratios

  • Debt-Equity Ratio

    0.76

  • Mar.Cap (₹Cr.)

    17,616.71

  • RONW (%)

    16.61

  • ROCE (%)

    12.06

Score Board

  • Equity (₹ in Cr.)

    13.86

  • BV (₹)

    230.60

  • Sales( ₹ in Cr.)

    1,821.74

  • NP (in Cr.)

    253.51

  • NP Var(%)

    240.0

  • Div%

    721.0

  • CPS (₹)

    29.40

  • EPS (₹)

    18.30

  • Traded Value (₹ in Lakhs)

    17,656.21

  • 52 Week High

    1,740.00

  • 52 Week Low

    1,200.00

  • Price BSE

    1274.0

  • Price NSE

    1,271.00

  • Market Capital( in Cr.)

    17,656.21

  • P/C Ratio

    43.30

  • P/E Ratio

    69.60

  • Price Vs.BV

    18.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,821.74 1,697.75 1,528.28 1,340.37 1,215.73 1,108.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,821.74 1,697.75 1,528.28 1,340.37 1,215.73 1,108.83
Other Income 98.31 35.51 34.83 17.26 28.99 10.00
Stock Adjustments -64.49 43.54 13.15 -8.50 -2.49 12.57
Total Income 1,855.56 1,776.80 1,576.26 1,349.13 1,242.23 1,131.40
EXPENDITURE :            
Raw Materials 562.21 542.79 293.31 227.88 197.16 211.08
Power and Fuel Cost 3.50 4.10 4.46 4.41 4.01 3.89
Employee Cost 340.62 361.92 331.67 252.52 220.11 207.02
Other Manufacturing Expenses 25.38 25.46 16.80 11.50 7.47 7.16
Selling and Administration Expenses 123.96 214.41 319.27 242.67 215.51 181.66
Miscellaneous Expenses 103.92 106.06 122.10 87.78 84.93 93.13
Employee Benefit Expenses 340.62 361.92 331.67 252.52 220.11 207.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,159.59 1,254.74 1,087.61 826.75 729.18 703.93
Operating Profit 695.97 522.06 488.65 522.38 513.04 427.47
Interest 179.54 220.24 57.42 20.81 3.05 0.94
Gross Profit 516.43 301.82 431.23 501.57 509.99 426.53
Depreciation 154.38 181.77 102.39 64.66 51.46 37.64
Profit Before Tax 362.05 120.05 328.84 436.91 458.53 388.89
Current Tax 60.96 21.98 57.64 76.50 80.17 70.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 57.04 20.68 -28.52 -37.59 -38.83 -31.90
Reported Net Profit 244.05 77.39 299.72 398.01 417.19 350.61
Extraordinary Items -9.46 2.83 2.79 5.17 -1.72 2.33
Adjusted Net Profit 253.51 74.56 296.93 392.84 418.91 348.28
Adjustment below Net Profit 0.69 -2.84 -2.76 -0.15 -1.01 -1.28
P & L Balance brought forward 2,461.66 2,487.17 2,190.21 1,892.28 1,557.74 1,283.09
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 100.06 0.00 99.93 81.65 74.68
P & L Balance carried down 2,706.40 2,461.66 2,487.17 2,190.21 1,892.28 1,557.74
Dividend 0.00 0.00 0.00 99.93 81.65 74.68
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 721.00 735.00 0.00 735.00 601.00 550.00
Dividend Per Share(Rs) 7.21 7.35 0.00 7.35 6.01 5.50
Earnings Per Share-Unit Curr 17.62 5.68 22.04 29.27 30.69 25.82
Earnings Per Share(Adj)-Unit Curr 17.62 5.68 22.04 29.27 30.69 25.82
Book Value 230.72 184.65 185.59 163.39 141.11 116.03
Book Value(Adj)-Unit Curr 230.72 184.65 185.59 163.39 141.11 116.03

Shareholding Pattern

  • Promoter Group

    54.14%

  • Public Share Holding

    45.86%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 75,022,837 54.14 75,022,837 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 75,022,837 54.14 75,022,837 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 10 0.00 10 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3 0.00 3 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,971,277 5.75 7,971,277 126
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,570,561 1.13 1,570,561 7
Mutual Funds / UTI 26,161,629 18.88 26,161,629 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 974,439 0.70 974,439 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 36,677,919 26.47 36,677,919 176
2] Non Institution
Bodies Corporate 405,759 0.29 405,759 263
Clearing Members 49,392 0.04 49,392 21
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 225,685 0.16 225,685 1,268
Foreign Non Institution Other 11,965,882 8.63 11,965,882 1
Hindu Undivided Families 100,646 0.07 100,646 1,068
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,319,584 7.45 10,319,584 5
Individuals holding nominal share capital up to Rs. 1 lakh 3,678,546 2.65 3,678,546 47,945
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,002 0.00 1,002 1
Others 65,633 0.05 65,633 2
Sub Total 26,877,733 19.40 26,877,733 50,617
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 138,578,489 100.00 138,578,489 50,798

Company Background

ERIS Lifesciences LtdPharmaceuticals - Indian - Formulations

  • ERIS Lifesciences Ltd
  • BSE Code : 66197.0
  • ISIN : INE406M01024

  • Incorporation Year

    2007

  • Registered Office

    8th Floor Commerce House -IV
    Prahladnagar 100 FT Road, Ahmedabad,
    Gujarat-380015

  • Telephone

    91-79-30451000

  • FAX

    91-79-48903474

  • Chairman

    Amit Indubhushan Bakshi

  • Managing Director

  • Company Secretary

    Milind Talegaonkar

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

ERIS Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ERIS Lifescience 1,274.05 1,920.05 1,821.74 91.79 10.66
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77